AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2017
Sep 27, 2017
32093_dirs_2017-09-26_d3a92a6d-b702-46f0-93de-2e122d4f4ecc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-09-24
Reporting Person: DUGGAN ROBERT W (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-24 | Common Stock | P | 2000000 | $15.02 | Acquired | 5797612 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 35000 | Indirect |
Footnotes
F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17